Lung Kee (Bermuda) Holdings Limited
Lung Kee (Bermuda) Holdings Limited Fundamental Analysis
Lung Kee (Bermuda) Holdings Limited (0255.HK) shows weak financial fundamentals with a PE ratio of -41.72, profit margin of -1.71%, and ROE of -1.44%. The company generates $1.3B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 34.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 0255.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak0255.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent0255.HK trades at attractive valuation levels.
Growth Score
Weak0255.HK faces weak or negative growth trends.
Financial Health Score
Excellent0255.HK maintains a strong and stable balance sheet.
Profitability Score
Weak0255.HK struggles to sustain strong margins.
Key Financial Metrics
Is 0255.HK Expensive or Cheap?
P/E Ratio
0255.HK trades at -41.72 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 0255.HK's PEG of 0.10 indicates potential undervaluation.
Price to Book
The market values Lung Kee (Bermuda) Holdings Limited at 0.61 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 14.19 times EBITDA. This signals the market has high growth expectations.
How Well Does 0255.HK Make Money?
Net Profit Margin
For every $100 in sales, Lung Kee (Bermuda) Holdings Limited keeps $-1.71 as profit after all expenses.
Operating Margin
Core operations generate 12.92 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.44 in profit for every $100 of shareholder equity.
ROA
Lung Kee (Bermuda) Holdings Limited generates $-1.24 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Lung Kee (Bermuda) Holdings Limited produces operating cash flow of $222.85M, showing steady but balanced cash generation.
Free Cash Flow
Lung Kee (Bermuda) Holdings Limited generates strong free cash flow of $179.59M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.28 in free cash annually.
FCF Yield
0255.HK converts 19.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-41.72
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.10
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.61
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.72
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.003
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.01
vs 25 benchmark
ROA
Return on assets percentage
-0.01
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How 0255.HK Stacks Against Its Sector Peers
| Metric | 0255.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -41.72 | 25.96 | Better (Cheaper) |
| ROE | -1.44% | 1263.00% | Weak |
| Net Margin | -1.71% | -41827.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.79 | Strong (Low Leverage) |
| Current Ratio | 6.13 | 10.05 | Strong Liquidity |
| ROA | -1.24% | -1497918.00% (disorted) | Weak |
0255.HK outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Lung Kee (Bermuda) Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure